Metformin for the Treatment of Diabetes in Pregnancy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00414245 |
Recruitment Status
: Unknown
Verified December 2006 by Soroka University Medical Center.
Recruitment status was: Not yet recruiting
First Posted
: December 21, 2006
Last Update Posted
: December 21, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Gestational Diabetes Diabetes Mellitus Type 2 | Drug: metformin | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 200 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Metformin for the Treatment of Diabetes in Pregnancy |
Study Start Date : | January 2007 |

- glycemic control
- pregnancy complications

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- pregnant women
- GDM A2
- diabetes mellitus type 2
- singleton pregnancy
Exclusion Criteria:
- diabetic nephropathy or proliferative retinopathy
- cannot swallow tablets

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00414245
Contact: Boaz Sheizaf, MD | 972-54-2401191 | bsheizaf@bgu.ac.il |
Israel | |
Division of Obstetrics and Gynecology, Soroka University Medical Center | Not yet recruiting |
Beer-Sheva, Israel | |
Contact: Boaz Sheizaf, MD 972-54-2401191 bsheizaf@bgu.ac.il | |
Principal Investigator: Boaz Sheizaf, MD |
Principal Investigator: | Boaz Sheizaf, MD | division of obstetrics and gynecology, soroka university medical center |
ClinicalTrials.gov Identifier: | NCT00414245 History of Changes |
Other Study ID Numbers: |
sor434306ctil |
First Posted: | December 21, 2006 Key Record Dates |
Last Update Posted: | December 21, 2006 |
Last Verified: | December 2006 |
Additional relevant MeSH terms:
Diabetes Mellitus Diabetes, Gestational Diabetes Mellitus, Type 2 Pregnancy in Diabetics Glucose Metabolism Disorders Metabolic Diseases |
Endocrine System Diseases Pregnancy Complications Metformin Hypoglycemic Agents Physiological Effects of Drugs |